Adalimumab Treatment in Patients with Vogt–Koyanagi–Harada Disease
Sign Up to like & getrecommendations! Published in 2018 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2016.1236969
Abstract: ABSTRACT Purpose: To evaluate the clinical outcome and safety of adalimumab in patients with Vogt–Koyanagi–Harada (VKH) disease. Methods: VKH patients treated with adalimumab seen at the University of Buenos Aires were reviewed. Main outcome measures… read more here.
Keywords: vogt koyanagi; treatment; patients vogt; adalimumab treatment ... See more keywords
FRI0125 Quantification of tumour necrosis factor in ankylosing spondylitis patients during adalimumab treatment
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.5419
Abstract: Background Tumour necrosis factor- (TNF) inhibitors, including adalimumab, are widely used in the treatment of inflammatory autoimmune diseases. Longitudinal (drug-bound) TNF levels in rheumatoid arthritis (RA) patients increased upon adalimumab treatment, and remained stable over… read more here.
Keywords: tnf; tnf levels; tumour necrosis; adalimumab treatment ... See more keywords
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Sign Up to like & getrecommendations! Published in 2017 at "Trials"
DOI: 10.1186/s13063-017-1848-0
Abstract: textabstractThe author initials were not complete in the original publication [1]. The correct initials should be: "CI Busard, SP Menting, JS van Bezooijen, JM van den Reek, BA Hutten, EP Prens, EM de Jong, MB… read more here.
Keywords: psoriasis concomitant; erratum optimizing; optimizing adalimumab; treatment psoriasis ... See more keywords
Ophthalmic use of TNFα inhibitor: adalimumab treatment in uveitis
Sign Up to like & getrecommendations! Published in 2021 at "Orvosi hetilap"
DOI: 10.1556/650.2021.32188
Abstract: Összefoglaló. Bevezetés: Az adalimumab egy TNFα-gátló monoklonális antitest; számos indikációja közül a nem fertőzéses eredetű intermedier, posterior és panuveitisek kezelésében is általánosan alkalmazható készítmény. Célkitűzés: A felnőttkori nem fertőzéses eredetű uveitis miatt adalimumabkezelést kapó betegekkel… read more here.
Keywords: adalimumab; esetben; treatment; ophthalmology ... See more keywords
Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10020324
Abstract: Interleukin (IL)-17 and tumor necrosis factor-alpha (TNF)-α are key players in psoriatic arthritis (PsA) pathogenesis. While both cytokines can be therapeutically targeted with beneficial clinical outcome, it is unclear whether inhibiting one cytokine will affect… read more here.
Keywords: adalimumab treatment; psa patients; skin synovium; psoriatic arthritis ... See more keywords